Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Lysine acetylation restricts mutant IDH2 activity to optimize transformation in AML cells
    Journal Article

    Chen, D.; Xia, S.; Zhang, R.; Li, Y.; Famulare, C. A.; Fan, H.; Wu, R.; Wang, M.; Zhu, A. C.; Elf, S. E.; more...
    Molecular Cell (2021)

    Fulltext@MSK | Save
  • Dual targeting of JAK2 and ERK interferes with the myeloproliferative neoplasm clone and enhances therapeutic efficacy
    Journal Article

    Brkic, S.; Stivala, S.; Santopolo, A.; Szybinski, J.; Jungius, S.; Passweg, J. R.; Tsakiris, D.; Dirnhofer, S.; Hutter, G.; Leonards, K.; more...
    Leukemia (2021)

    Fulltext@MSK | Save
  • Measurable residual disease negativity in acute myeloid leukemia: The destination may matter more than the journey
    Editorial

    Stahl, M.; Tallman, M. S.; Goldberg, A. D.
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Human cytomegalovirus expands a CD8(+) T cell population with loss of BCL11B expression and gain of NK cell identity
    Journal Article

    Sottile, R.; Panjwani, M. K.; Lau, C. M.; Daniyan, A. F.; Tanaka, K.; Barker, J. N.; Brentjens, R. J.; Sun, J. C.; Le Luduec, J. B.; Hsu, K. C.
    Science Immunology (2021)

    Fulltext@MSK | Save
  • Clonal hematopoiesis is associated with risk of severe COVID-19
    Journal Article

    Bolton, K. L.; Koh, Y.; Foote, M. B.; Im, H.; Jee, J.; Sun, C. H.; Safonov, A.; Ptashkin, R.; Moon, J. H.; Lee, J. Y.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Acute lymphoblastic leukemia, version 2.2021: NCCN Clinical Practice Guidelines in Oncology
    Guidelines

    Brown, P. A.; Shah, B.; Advani, A.; Aoun, P.; Boyer, M. W.; Burke, P. W.; DeAngelo, D. J.; Dinner, S.; Fathi, A. T.; Gauthier, J.; more...
    Journal of the National Comprehensive Cancer Network (2021)

    Fulltext@MSK | Save
  • Comparative mutational profiling of hematopoietic progenitor cells and circulating endothelial cells (CECs) in patients with primary myelofibrosis
    Journal Article

    Farina, M.; Bernardi, S.; Polverelli, N.; D’Adda, M.; Malagola, M.; Bosio, K.; Re, F.; Almici, C.; Dunbar, A.; Levine, R. L.; more...
    Cells (2021)

    Fulltext@MSK | Save
  • TET2 and DNMT3A mutations exert divergent effects on DNA repair and sensitivity of leukemia cells to PARP inhibitors
    Journal Article

    Maifrede, S.; Le, B. V.; Nieborowska-Skorska, M.; Golovine, K.; Sullivan-Reed, K.; Dunuwille, W. M. B.; Nacson, J.; Hulse, M.; Keith, K.; Madzo, J.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • A tumor-agnostic TCR-mimic CAR-T cell specific for NDC80 targets multiple hematological malignancies
    Meeting Abstract

    Klatt, M. G.; Dao, T.; Yang, Z.; Liu, J.; Mun, S. S.; Dacek, M. M.; Luo, H.; Gardner, T. J.; Bourne, C.; Peraro, L.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Pirtobrutinib (LOXO-305), a next-generation, highly selective, non-covalent Bruton's tyrosine kinase inhibitor in previously treated mantle cell lymphoma and other non-Hodgkin lymphomas: Phase 1/2 BRUIN study results
    Meeting Abstract

    Cohen, J. B.; Shah, N. N.; Alencar, A. J.; Gerson, J. N.; Patel, M. R.; Fahkri, B.; Jurczak, W.; Tan, X. N.; Lewis, K. L.; Fenske, T. S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save